Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8 ⁺ effector memory T cells

Abstract

Findings from this study provide a new basis for the development of therapeutic pHBV-vaccine, which might be a potential candidate for clinical CHB therapy.